KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) - Dilution Analysis

Visualizing historical and potential share dilution over time

View Stock Details

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Dilution Analysis

High Risk

Significant dilution risk

Last updated: December 01, 2025

Risk Assessment Details

Potential Dilution: 31.82% of current shares

Recent Dilution: 36.38% (2 years)

Historical Dilution Factor: significant recent dilution

Outstanding Shares

51M

Potential Supply

16M

Additional shares possible

Splits

None

Past 2 years

Summary

KMTS currently has 51.3M outstanding shares. with moderate dilution risk from 16.3M authorized shares representing 31.8% potential dilution. The company has significantly diluted shareholders by 36.38% over the past 2 years, indicating aggressive capital raising.

Share Structure Timeline

Outstanding Shares

Total Supply

Historical Data Points

Date	Event	Outstanding	Supply
Dec 01, 2025	S-1 filing: This is an S-1 filing for an initial public offering of common shares.	51M	16M
Sep 12, 2025	10-Q filing \| 51.3M shares outstanding	51M	10M
Jul 17, 2025	10-K filing \| 51.3M shares outstanding	51M	10M
Apr 17, 2025	10-Q filing \| 51.3M shares outstanding	51M	10M
Mar 03, 2025	S-1/A filing: This is an S-1/A filing with exhibits related to warrants, agreements, and other corporate documents for Kestra Medical Technologies, Ltd.	38M	10M
Feb 26, 2025	S-1/A filing: This S-1/A filing details the potential dilution effect of a proposed offering of 10,000,000 common shares at an assumed initial public offering price of $15.00 per share.	38M	10M
Feb 10, 2025	S-1 filing: This is an S-1 filing for the initial public offering of Kestra Medical Technologies, Ltd., involving common shares.	N/A	0

Back to KMTS Details